– The net sales and operating profit for Q2 hit KRW110.3 billion and KRW56.7 billion, up 15.5% and 33.6% on-year, respectively

– The sales overseas, led by launch of the toxin in the US and expanded shipments to China this year, drive strong outcome

– Net sales in cosmetics, the new growth engine, show a 104.5% increase on-year in Q2

SEOUL, South Korea, Aug. 6, 2025 /PRNewswire/ — Hugel Inc., a leading global medical aesthetics company, announced its consolidated financial results for the second quarter of 2025 on Wednesday. The company posted KRW110.3 billion in net sales, KRW56.7 billion in operating profit, and KRW38.2 billion in net income, representing on-year increases of 15.5%, 33.6%, and 3.3%, respectively. These results mark the highest quarterly figures in the company’s history and contributed to a record first-half performance.


Hugel Inc. (PRNewsfoto/Hugel)

Full story available on Benzinga.com